Yang G, Wang X, Yang Y, Yang R, Gowetski DB, Paula. Quantitation of residual valproic acid in flu vaccine drug substance. J Chromatogr B Analyt Technol Biomed Life Sci. 202
Quantitative measurement of process-related impurities is a critical safety requirement for the production of drug substances of vaccine and therapeutic biologics. A simple and sensitive HPLC method has been developed for separation and quantitation of residual valproic acid (VPA) used in the cell transfection procedure for the manufacturing of an influenza vaccine. The method is comprised of a modified Dole liquid phase extraction followed by a quick pre-column derivatization using 2-bromoacetophenone. Nonanoic acid (NNA) is used as the internal standard (IS) and the quantification is performed by reversed-phase liquid chromatography. This new method can accurately measure as low as 6.8 μg/mL (LOQ) residual VPA in the vaccine drug substance.
See Also:
Latest articles in those days:
- Manganese exposure in juvenile C57BL/6 mice increases glial inflammatory responses in the substantia nigra following infection with H1N1 influenza virus 12 hours ago
- G-quadruplexes in H1N1 influenza genomes 23 hours ago
- A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity 3 days ago
- In silico prediction of influenza vaccine effectiveness by sequence analysis 3 days ago
- Pathogenicity and transmissibility assessment of two strains of human influenza virus isolated in China in 2018 4 days ago
[Go Top] [Close Window]